These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31302083)

  • 1. Stent Thrombosis After Short-term Discontinuation of Ticagrelor for Coronary Artery Bypass Grafting.
    Nam SH; Kim H; Ro SK
    Ann Thorac Surg; 2020 Apr; 109(4):e289-e291. PubMed ID: 31302083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding in Patients Treated With Ticagrelor or Clopidogrel Before Coronary Artery Bypass Grafting.
    Holm M; Biancari F; Khodabandeh S; Gherli R; Airaksinen J; Mariscalco G; Gatti G; Reichart D; Onorati F; De Feo M; Santarpino G; Rubino AS; Maselli D; Santini F; Nicolini F; Zanobini M; Kinnunen EM; Ruggieri VG; Perrotti A; Rosato S; Dalén M
    Ann Thorac Surg; 2019 Jun; 107(6):1690-1698. PubMed ID: 30898561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation].
    Decoene C; Vincentelli A; Fabre O; Crepin F; Pol A
    Ann Fr Anesth Reanim; 2005 Oct; 24(10):1275-7. PubMed ID: 16125359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery.
    Hansson EC; Malm CJ; Hesse C; Hornestam B; Dellborg M; Rexius H; Jeppsson A
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):633-637. PubMed ID: 28007881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved ticagrelor antiplatelet effect on discontinuation of phenytoin.
    Weeks P; Sieg A; Vahdat K; Raissi F; Nathan S
    Ann Pharmacother; 2014 May; 48(5):644-7. PubMed ID: 24477376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes.
    Diab S; Arazi M; Sternik L; Raanani E; Kachel E; Grosman-Rimon L; Shalabi A; Amir O; Carasso S
    J Cardiothorac Surg; 2021 May; 16(1):139. PubMed ID: 34022927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very late coronary stent thrombosis after discontinuation of antiplatelet therapy.
    Cardona L; Simas A; Lousinha A; Fiarresga AL; de Sousa L; Cacela D; Patrício L; Bernardes L; Ferreira R
    Rev Port Cardiol; 2011 Mar; 30(3):333-9. PubMed ID: 21638991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of dual antiplatelet therapy and bleeding in intensive care in patients undergoing urgent coronary artery bypass grafting: a retrospective analysis.
    Vuilliomenet T; Gebhard C; Bizzozero C; Glauser S; Blum S; Buser A; Bolliger D; Grapow MTR; Siegemund M
    Interact Cardiovasc Thorac Surg; 2019 May; 28(5):665-673. PubMed ID: 30535154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Treatment of Subacute Right Coronary Artery Stent Thrombosis After Dual- Antiplatelet Therapy Interruption for Coronary Artery Bypass Grafting Surgery.
    Gray L; Kuntz G; Ganapathi A; Bigelow G; Whitson B; Awad H; Graul T; Bailey T; Ryu J; Flores A; Essandoh M
    J Cardiothorac Vasc Anesth; 2023 Jul; 37(7):1236-1240. PubMed ID: 36967262
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring platelet reactivity during prasugrel or ticagrelor washout before urgent coronary artery bypass grafting.
    Orvin K; Barac YD; Kornowski R; Perl L; Wasserstrum Y; Rubchevsky V; Sharony R; Snir E; Aravot D; Lev EI
    Coron Artery Dis; 2017 Sep; 28(6):465-471. PubMed ID: 28763341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to dual antiplatelet therapy with ticagrelor in patients with acute coronary syndromes treated with percutaneous coronary intervention in real life. Results of the REAL-TICA registry.
    Zeymer U; Cully M; Hochadel M
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):205-210. PubMed ID: 29878086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study.
    Hansson EC; Jidéus L; Åberg B; Bjursten H; Dreifaldt M; Holmgren A; Ivert T; Nozohoor S; Barbu M; Svedjeholm R; Jeppsson A
    Eur Heart J; 2016 Jan; 37(2):189-97. PubMed ID: 26330426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.
    Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR;
    Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment.
    Tomšič A; Schotborgh MA; Manshanden JS; Li WW; de Mol BA
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):849-856. PubMed ID: 27174551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Koul S; Smith JG; Götberg M; Omerovic E; Alfredsson J; Venetsanos D; Persson J; Jensen J; Lagerqvist B; Redfors B; James S; Erlinge D
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005528. PubMed ID: 29870381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
    Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
    JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series.
    Bowman S; Gass J; Weeks P
    Ann Pharmacother; 2019 Feb; 53(2):171-177. PubMed ID: 30132336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late and very late drug-eluting stent thrombosis in the immediate postoperative period after antiplatelet withdrawal: a retrospective study.
    Omar HR; Sprenker C; Karlnoski R; Camporesi EM; Mangar D
    Ther Adv Cardiovasc Dis; 2014 Oct; 8(5):185-92. PubMed ID: 25015068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.